Carl Zeiss Meditec AG

Factors to consider:

• Company pays dividends (annually): last record date 2026-03-30, amount 0.63$ (Y2.11%)
• Earnings for 18 months up through Q2 (+1 year) are close to our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-09-30 to 2026-09-30

• 2024-09-30 to 2025-09-30 estimated range: [41.48$, 87.98$]
• 2025-09-30 to 2026-09-30 estimated range: [40.23$, 83.68$]

Financial Metrics affecting the CZMWF estimates:

• Negative: with PPE of 30.1 at the end of fiscal year the price was high
• Positive: -5.39 < Operating profit margin, % of 5.87
• Positive: 1.81 < Return on assets ratio (scaled to [-100,100]) of 5.04
• Positive: -0.02 < Operating cash flow per share per price, % of 4.75
• Negative: negative Industry operating cash flow (median)
• Positive: -14.17 < Investing cash flow per share per price, % of -7.91
• Positive: 42.59 < Shareholder equity ratio, % of 60.17 <= 64.29
• Positive: Interest expense per share per price, % of 0.56 <= 0.73